Neurogene Inc. (NASDAQ: NGNE) Stock Information | RedChip

Neurogene Inc. (NASDAQ: NGNE) Listen to this Section


$34.84
-0.7800 ( -2.19% ) 45.2K

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Market Data


Open


$34.84

Previous close


$35.62

Volume


45.2K

Market cap


$455.04M

Day range


$34.50 - $36.92

52 week range


$12.49 - $53.00

Insider Ownership Transactions

Total Amount Purchased: -58,455.00 | $ -2,036,572.20

Date Type Amount Purchased Purchaser
2024-01-18 Sale -15400.00 PALEKAR ROHAN
2024-01-18 Sale -15400.00 Noonberg Sarah B.
2024-01-18 Sale -15400.00 Freedland Cory S.
2024-01-18 Sale -15400.00 BAFFI ROBERT
2023-12-20 Sale -78325.00 BAKER BROS. ADVISORS LP
2023-10-10 Sale -57049.00 BAKER BROS. ADVISORS LP
2023-08-17 Buy 143519.00 BAKER BROS. ADVISORS LP
2023-08-14 Sale -5000.00 Smith Sean Michael

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 17, 2024
8-k 8K-related 15 Jun 03, 2024
10-q Quarterly Reports 80 May 10, 2024
8-k 8K-related 52 May 10, 2024
8-k 8K-related 15 May 07, 2024
ars Annual reports 1 Apr 26, 2024
def Proxies and info statements 22 Apr 26, 2024
8-k 8K-related 13 Apr 25, 2024
8-k 8K-related 15 Apr 22, 2024
8-k 8K-related 13 Apr 02, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.